The effect of passive opium smoking on cardiovascular indices of rabbits with normal and ischemic hearts

Open Cardiovascular Medicine Journal

Volumn 4, Issue , 2010, Pages 1-6

  Joukar, Siyavash ^a   Najafipour, Hamid ^b   Malekpour Afshar, Reza ^b   Mirzaeipour, Fatemeh ^a   Nasri, Hamid Reza ^a  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardiac ischemia; Cardiac troponin I; Histopathology; Opium smoking

Indexed keywords

ISOPRENALINE; OPIATE; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR EFFECT; CELL INFILTRATION; CONTROLLED STUDY; ELECTROCARDIOGRAM; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART TISSUE CONGESTION; HEART TISSUE HEMORRHAGE; HISTOPATHOLOGY; HYPEREOSINOPHILIC BUNDLE; LEUKOCYTE; MEAN ARTERIAL PRESSURE; MUSCLE ATROPHY; NONHUMAN; PASSIVE OPIUM SMOKING; PASSIVE SMOKING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; Q WAVE; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION;

EID: 78249267268     PISSN: None     EISSN: 18741924     Source Type: Journal    
DOI: 10.2174/1874192401004010001     Document Type: Article

References (16)

1. Nissaramanesh B, Trace M, Roberts M. The rise of harm reduction in the islamic republic of Iran. The Beckley Foundation Drug Policy Programme July, 2005.
2. Asgary S, Sarrafzadegan N, Naderi GA, Rozbehani R. Effect of opium addiction on new and traditional cardiovascular risk factors: do duration of addiction and route of administration matter? Lipids Health Dis 2008; 7: 42.
3. Sadr BSM, Rafiei M, Bahadorzadeh L, et al. Is opium addiction a risk factor for acute myocardial infarction? Acta Med Iran 2005; 43: 218-22.
4. Sadeghian S, Darvish S, Davoodi G, Salarifar M, Mahmoodian M, Fallah N. The association of opium with coronary artery disease. Eur J Cardiovasc Prev Rehabil 2007; 14: 715-7.
5. Davoodi G, Sadeghian S, Akhondzadeh S, Darvish S, Alidoosti M, Amirzadegan A. Comparison of specifications, short term outcome and prognosis of acute myocardial infarction in opium dependent patients and nondependents. J Tehran Heart Center 2006; 1: 43-7.
6. Azimzade-Sarwar B, Gholamreza YG, Narooey S. A case-control study of effect of opium addiction on myocardial infarction. Am J Appl Sci 2005; 2: 1134-5.
7. Peart JN, Gross ER, Gross GJ. Opioid-induced preconditioning: Recent advances and future perspectives (Review). Vasc Pharmacol 2005; 42:211-8.
8. Yamatsu K, Takagi H. Electeroencephalographic studies on morphine dependence in rabbit. Jpn J Pharmacol 1966; 2: 225-7.
9. Pinelli A, Trivulzio S, Tomasoni L, Brennab S, Bonacina E, Accinni R. Isoproterenol-induced myocardial infarction in rabbits. Protection by propranolol or labetalol: a proposed non-invasive procedure. Eur J Pharm Sci 2004; 23: 277-85.
10. Pinelli A, Trivulzio S, Tomasoni L, et al. Myocardial infarction non-invasively induced in rabbits by administering isoproterenol and vasopressin: protective effects exerted by verapamil. Fundam Clin Pharmacol 2004; 18; 657-67.
11. Peacock WF, Hollander JE, Diercks DB, Lopatin M, Fonarow G, Emerman CL. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis. Emerg Med J 2008; 25: 205-9.
12. Wallner C, Stollberger C, Hlavin A, Finsterer J, Hager I, Hermann P. Electrocardiographic abnormalities in opiate addicts. Addiction 2008; 103:1987-93.
13. Feuerstein G, Siren AL. The opioid peptides. A role in hypertension? Hypertension 1987; 9: 561-5.
14. Hill-Pryor C, Lindsey D, Lapanowski K, Dunbar JC. The cardiovascular responses to mu opioid agonist and antagonist in conscious normal and obese rats. Peptides 2006; 27: 1520-6.
15. Fontana F, Bernardi P, Spampinato S, Boschi S, De Iasio R, Grossi G. Pressor effects of endogenous opioid system during acute episodes of blood pressure increases in hypertensive patients. Hypertension 1997; 29:105-10.
16. Verde MCM, Díaz-Flores JF, Sañudo RI, Rodríguez REM, Díaz Romero C. Haematologic parameters in opiate addicts. Nutr Hosp 2003; 18:358-65.